In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine

Citation
T. Goto et al., In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine, UROLOGY, 53(5), 1999, pp. 1058-1062
Citations number
22
Categorie Soggetti
Urology & Nephrology
Journal title
UROLOGY
ISSN journal
00904295 → ACNP
Volume
53
Issue
5
Year of publication
1999
Pages
1058 - 1062
Database
ISI
SICI code
0090-4295(199905)53:5<1058:IVBAOB>2.0.ZU;2-I
Abstract
Objectives. To compare bactericidal activities of antimicrobial agents agai nst Pseudomonas aeruginosa biofilms by employing an in vitro model of cathe ter-associated infection because such infections are refractory to antimicr obial treatment. Methods. Bactericidal activities of piperacillin (PIPC), ceftazidime (CAZ), panipenem (PAPM), amikacin (AMK), ciprofloxacin (CPFX), and levofloxacin ( LVFX) were examined against a P. aeruginosa biofilm generated on a Teflon c atheter in artificial urine. The colony-forming activities of biofilm bacte ria were determined for 48 hours during the treatment with each drug at con centrations of 1 up to 128 times the minimal bactericidal concentration (MB C), and time-kill curves were constructed by plotting the viable cell count s against time. Results. Although CAZ was more bactericidal to the biofilm bacteria than PI PC, the biofilm bacteria still remained on the catheter during CAZ treatmen t at a concentration 128 times the MBC for 48 hours, Biofilm bacteria were completely eradicated within 48 hours by treatment with PAPM and AMK at a c oncentration 64 and 128 times the MBC, respectively. Both CPFX and LVFX era dicated biofilm bacteria completely by 24 hours at a concentration 32 times the MBC. Conclusions. These results indicate that fluoroquinolones have the most pot ent bactericidal activity against the P. aeruginosa biofilm generated in ur ine. UROLOGY 53: 1058-1062, 1999. (C) 1999, Elsevier Science Inc. All right s reserved.